A recent study showed that LrB could reduce the severity of inflammation in Crohn’s disease colon by inhibiting the expression levels of inflammatory cytokines interleukin-1 (IL-1), IL-6 and tumor necrosis factor-alpha (TNF-α) (7). This evidence concerns the gene TNF and Crohn disease.